Related content

The Extended Adjuvant Treatment Strategy in Early Breast Cancer: A New Standard of Care?

By Smith Ian E.  

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

New Strategies for Treating GIST When Imatinib Fails

By Boyar Michelle S.   Taub Robert N.  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 328-335

Informa Healthcare

Access to resources Recommend Favorite

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with exon 11 mutation

By Kang Yoon-Koo   Kang Byung   Im Seock-Ah   Lee Jae-Lyun   Park Sook   Kang Won   Chang Heung   Kim Tae   Oh Do-Youn   Jung Kyung   Ryu Min-Hee  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 43-51

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of a GIST patient with modified dose of sunitinib by measurement of plasma drug concentrations

By                    

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 501-504

Spandidos Publications

Access to resources Recommend Favorite

Curcumin as an Adjuvant to Breast Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 5, 2015-01 ,pp. : 647-656

Bentham Science Publishers

Access to resources Recommend Favorite